Ovid Therapeutics Inc. (OVID)
NASDAQ · Healthcare
Ovid Therapeutics Inc. Operating Income 2020–2025
Ovid Therapeutics Inc. annual/quarterly operating income history and growth rate from 2020 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Ovid Therapeutics Inc. operating income for the quarter ending March 31, 2026 was -17.8 M, a 42.20% increase year-over-year.
- Ovid Therapeutics Inc. operating income for the twelve months ending March 31, 2026 was -48.0 M, a 24.05% decrease year-over-year.
- Ovid Therapeutics Inc. annual operating income for 2025 was -42.4 M, a 31.42% decrease from 2024.
- Ovid Therapeutics Inc. annual operating income for 2024 was -61.9 M, a 4.39% increase from 2023.
- Ovid Therapeutics Inc. annual operating income for 2023 was -59.3 M, a 6.72% increase from 2022.
- Ovid Therapeutics Inc. annual operating income for 2022 was -55.5 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Ovid Therapeutics Inc. Operating Income — FAQ
Ovid Therapeutics Inc. (OVID) operating income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Ovid Therapeutics Inc.'s operating income?
Ovid Therapeutics Inc. (OVID) reported operating income of -$42M for fiscal 2025.
Where can I see OVID's operating income history?
The chart and table above show Ovid Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.